HCC-derived EV-miR-103 and miR-210 interact with endothelial cells, leading to their altered integrity and signal transducer and activator of transcription 6 (STAT6) and SMAD family member 4 (SMAD4) overexpression, respectively [106]. The gene discussed is SMAD4; the disease is hepatocellular carcinoma.